Arkea Bio

Arkea Bio develops technology to cut greenhouse gas (GHG) emissions from the agricultural industry.

Health and bioClimate and energy

Arkea Bio raised $15M in a Series A round announced September 29, 2026, according to pomegra.io. Investors in that round: AgriZeroNZ, Breakthrough Energy Ventures.

Founders and team

• CS
  Colin South Founder

  source: crunchbase.com
• FW
  Frank Wooten CEO

  source: crunchbase.com
• CR
  Chris Rivest Board member

  source: crunchbase.com
• ZS
  Zach Serber Chief Technology Officer

  source: crunchbase.com

Raise history

1. September 29, 2026
   Series A · $15M
   AAgriZeroNZ (lead), BBreakthrough Energy Ventures
   Source: pomegra.io
2. June 5, 2021
   Website created

Investors

• AAgriZeroNZ
• BBreakthrough Energy Ventures
• GGrantham Foundation
• OOverview
• RRabo Ventures
• TThe51 Food & AgTech Fund

Related bio health companies

• TTriGemX Bio$94M · Oct 1, 2026
• SSedMed$4M · Oct 1, 2026
• SSharp$328K · Oct 1, 2026
• MM-BasedOct 1, 2026
• AAyna HealthOct 1, 2026
• BBiotia$9M · Oct 1, 2026
• RR1 Therapeutics$80.5M · Sep 30, 2026
• LLinux Laboratories$70M · Sep 30, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/arkea-bio.